Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | %Female (2021) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Theranostics | journal | 2.061 Q1 | 158 | 557 | 1796 | 39471 | 20798 | 1786 | 10.94 | 70.86 | 40.46 |  |
| 2 | Biomarker Insights | journal | 1.108 Q1 | 40 | 18 | 57 | 962 | 303 | 54 | 3.21 | 53.44 | 36.67 |  |
| 3 | International Journal of Nanomedicine | journal | 1.032 Q1 | 179 | 496 | 1968 | 35384 | 14741 | 1965 | 7.10 | 71.34 | 43.82 | |
| 4 | Infection and Drug Resistance | journal | 0.944 Q1 | 65 | 542 | 1115 | 21858 | 5304 | 1098 | 4.33 | 40.33 | 42.36 | |
| 5 | Open Access Journal of Clinical Trials | journal | 0.785 Q1 | 15 | 6 | 17 | 202 | 16 | 17 | 1.17 | 33.67 | 52.94 | |
| 6 | Drug Design, Development and Therapy | journal | 0.784 Q1 | 94 | 383 | 1221 | 19429 | 5845 | 1208 | 4.34 | 50.73 | 44.32 | |
| 7 | Diabetes, Metabolic Syndrome and Obesity | journal | 0.685 Q2 | 64 | 436 | 822 | 20400 | 2784 | 813 | 3.29 | 46.79 | 45.17 | |
| 8 | Pharmacogenomics and Personalized Medicine | journal | 0.683 Q2 | 37 | 151 | 127 | 6728 | 411 | 127 | 2.65 | 44.56 | 50.36 | |
| 9 | Patient Preference and Adherence | journal | 0.629 Q1 | 67 | 264 | 704 | 10708 | 1898 | 694 | 2.30 | 40.56 | 49.89 | |
| 10 | Nanotechnology, Science and Applications | journal | 0.619 Q2 | 35 | 13 | 18 | 1039 | 97 | 18 | 4.40 | 79.92 | 44.83 | |
| 11 | Drug, Healthcare and Patient Safety | journal | 0.355 Q3 | 30 | 25 | 58 | 1032 | 97 | 58 | 1.45 | 41.28 | 38.95 | |
| 12 | Fluoride - Quarterly Reports | journal | 0.247 Q4 | 51 | 12 | 121 | 397 | 119 | 110 | 0.79 | 33.08 | 32.61 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data